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For every complex problem there is an answer that is 









Cardiovascular disease (CVD) and other lifestyle related chronic diseases are increasing at an 
alarming rate both in Australia and around the world. While Primary Health Care (PHC) has a 
key role in addressing CVD prevention, a large evidence to practice gap exists. The Expanded 
Chronic Care Model (ECCM) has emerged as a leading approach to chronic disease 
management. This model proposes a comprehensive approach to disease management that 
adds prevention and health promotion to direct clinical care. While elements of the ECCM 
have been implemented within Australia, a full comprehensive application and evaluation of 
the model has not been carried out. This research addresses this gap in knowledge.  
Using the ECCM as a basis, the role and capacity of the community-based lifestyle 
modification workforce to support PHC in the management of CVD and behaviour change for 
risk reduction were examined. The feasibility, effectiveness and sustainability of this 
augmented approach to care were examined along with broader implications related to 




A mixed methods approach, embedded within an overarching case study in a single 
Australian jurisdiction (the Australian Capital Territory), was used to provide an integrated 
understanding of the real-world challenges of undertaking CVD management and prevention 
in contemporary PHC practice. The research design was guided by a number of interrelating 
theoretical and framing approaches governing different aspects of the research including: the 
transtheoretical model (stages of change); normalisation process theory; the expanded chronic 
care model and the complex adaptive system approach. A wide range of data was collected to 
examine the feasibility and effectiveness of the approach and to understand critical success 
factors for its implementation and sustainability. A one-group pre-post quasi experimental 
study was conducted to estimate health effects or assess process challenges and outcomes. 
Quantitative data from patient surveys and general practice clinical information systems were 
gathered and analysed. Process evaluation was conducted using surveys and clinical 
information systems data. Qualitative data were collected using semi-structured or focus 
 vi 
group interviews with: intervention participants; patients not responding to the intervention 
invitation; general practice staff; lifestyle advisors (health coaches); allied health 
professionals; and community-based lifestyle modification programme providers. All data 
were analysed separately using descriptive and inferential statistics for the quantitative data 
and both thematic and single coding analyses for the qualitative data.  Pattern matching was 




The intervention led to positive health and systems outcomes. There was a statistically 
significant reduction in population CVD absolute risk of 2.26%. Study programme 
participants were mostly satisfied with the service provided and all reported making positive 
changes to the health behaviours relevant to them. Patients who did not respond to the 
invitation to participate in the intervention reported varying levels of heart health education 
by general practitioners and practice nurses and only 44% had received a ‘heart and stroke 
check’ in the last two years. Interviews with these non-respondents highlighted that: existing 
relationship with a GP; apprehension to address CVD risk; and a low priority of addressing 
CVD risk influenced their choices not to participate. Further qualitative investigation revealed 
that more effort would be needed across multiple levels and stakeholders to implement such a 
complex intervention and embed evidence-based change into practice. Key barriers identified 
were: current funding mechanisms; the challenging nature of lifestyle modification; and the 
low value proposition of CVD prevention. The community-based sector, including allied 
health professionals and lifestyle modification programme providers, were highly motivated 
to contribute to CVD prevention but were underutilised and considered the level of funding 
available to be inadequate. The low value placed on and the ‘hard work’ of prevention was 
also noted. A need to improve cross-sector linkages were also highlighted.  
Overall, the case study propositions were confirmed, with the Expanded Chronic Care Model 
proving a useful framework to develop a whole-of-system approach to CVD prevention. An 
emergent theme from the research was that this chronic disease management system 
demonstrated many of the features of a complex adaptive system. These findings were 
synthesised into a complexity-informed Enhanced Chronic Care Model, providing both an 
explanation of the study outcomes and suggesting how best to progress ‘evidence to practice’ 





Reorientation of primary health care systems towards prevention continues to be highly 
resistant to change. The research undertaken here demonstrated that moving towards a CVD 
prevention-orientated PHC will need: 1. An improved value proposition for CVD prevention, 
2. Better local health intelligence, 3. Enhanced relationships between all stakeholders,4. A 
PHC workforce that has the skills to leverage added value to the system and 5. A more 
supportive policy environment.  
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Preface 
I did not always dream of being a dietitian. However, I did want a career with purpose, and 
what better purpose than to work to ensure that people have the basic human right of good 
nutrition. Over my career, a commitment to social justice and desire to work collaboratively 
with like-minded colleagues has led me on an incredible journey. As an Accredited Practising 
Dietitian, I have worked at all levels of Australian government, and in many roles with the 
non-government sector. I have worked in the bush, managed community health teams and 
been an accreditor for community health centres. I have worked in the Aboriginal Community 
Controlled Sector, at a national level, and locally with Winnunga Nimmityjah Aboriginal 
Health Service. I led professional services at the Dietitians Association of Australia and with 
the Heart Foundation I led an interdisciplinary team which included dietitians, nurses, school 
teachers, urban planners and fitness leaders. Most recently, I have shared my experiences as a 
university lecturer. I have been the funder and the fundee, the regulator and the regulated, the 
teacher and the student. I see health as a system as experience has taught me that you cannot 
make a difference by working in a straight line.  
 
As is true of all research, all of these experiences have influenced this research. While 
working with the Heart Foundation, it was a short meeting with Professor Rachel Davey, then 
newly arrived in Australia, that led to the development of a proposal for HeartLink. The 
HeartLink pilot program forms the basis of this doctoral study. HeartLink aimed to improve 
assessment, and management, of cardiovascular disease absolute risk in general practice and 
provide enhanced support for health behaviour change in the practice, and community 
settings. I worked on many aspects of the implementation of HeartLink including the 
development of the health coaching service and delivering many professional development 
activities. The aim of my doctoral research was to measure the health and process outcomes 
achieved by HeartLink, but also to delve deeply into the work undertaken by all stakeholders 
to implement a complex intervention in the real world.  
 
In case study research, the researcher is often considered an intruder who is there to observe 
how a system dynamic unfolds (Anderson et al. 2005). While my background in healthcare is 
extensive, I did feel like an intruder during some aspects of the study. I had never worked in a 
general practice and each HeartLink practice was a unique organisation with its own culture 
and way of doing the business of primary health care.                                              
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Nevertheless, not all of the context for the study was unfamiliar. As a health professional, I 
had a shared background with many of the practitioner participants in the study. I have also 
spent many years working with patients of the same age, and experiencing the same health 
issues, as the HeartLink participants.  
 
Malterud (2001) challenges researchers to identify personal motivations and preconceptions 
about their study, and their study participants. As a health professional, I came to this doctoral 
study with a desire to build on my existing experience and contribute new insights to an 
important area of practice. As a researcher, I acknowledge my role as ‘researcher-as-
instrument’ and was mindful of how I brought my professional, personal and researcher 
worlds together to achieve the best outcome, incorporating reflexivity into all aspects of my 
research process (Hammersley & Atkinson 1995).  
